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Abstract  
Trichotillomania is characterized by repetitive pulling out of one’s own hair. Impaired 
response inhibition has been identified in patients with trichotillomania, along with grey 
matter density changes in distributed neural regions including frontal cortex. The 
objective of this study was to evaluate impaired response inhibition and abnormal cortical 
morphology as candidate endophenotypes for the disorder. Subjects with trichotillomania 
(N=12), unaffected first-degree relatives of these patients (N=10), and healthy controls 
(N=14), completed the Stop Signal Task (SST), a measure of response inhibition, and 
structural magnetic resonance imaging scans. Group differences in SST performance and 
cortical thickness were explored using permutation testing. Groups differed significantly 
in response inhibition, with patients demonstrating impaired performance versus controls, 
and relatives occupying an intermediate position. Permutation cluster analysis revealed 
significant excesses of cortical thickness in patients and their relatives compared to 
controls, in right inferior/middle frontal gyri (Brodmann Area, BA 47 & 11), right lingual 
gyrus (BA 18), left superior temporal cortex (BA 21), and left precuneus (BA 7). No 
significant differences emerged between groups for striatum or cerebellar volumes. 
Impaired response inhibition and an excess of cortical thickness in neural regions 
germane to inhibitory control, and action monitoring, represent vulnerability markers for 
trichotillomania. Future work should explore genetic and environmental associations with 
these biological markers 
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Introduction 
Trichotillomania (also known as Hair Pulling Disorder) is an often debilitating 
psychiatric condition characterized by recurrent pulling out of one’s own hair, leading to 
hair loss and marked functional impairment (Odlaug et al., 2010; Woods et al., 2006). 
While the phenomenon of hair pulling has been described since antiquity (such as in 
work attributed to Hippocrates), trichotillomania was first recognized as a distinct clinical 
entity by the French dermatologist Francois Hallopeau in the 19
th
 Century (Hallopeau 
1889). Subsequently, trichotillomania was incorporated into psychiatric nosology, first as 
an Impulse Control Disorder in the Diagnostic and Statistical Manual 3
rd
 Edition (DSM-
III-R), and then as an Obsessive Compulsive Related Disorder in the 5
th
 Edition (DSM-5).  
The clinical and research importance of trichotillomania is increasingly recognized. Far 
from being rare, trichotillomania is relatively common, with point prevalence estimates 
of 0.5-4%  (Odlaug and Grant, 2010) and lifetime prevalence estimates of around 0.6% 
(Christenson et al., 1991). Animal models of excessive grooming have been widely 
touted as being valuable not only in understanding the neurobiology human 
trichotillomania, but also other disorders more broadly, especially obsessive compulsive 
disorder (OCD) (e.g. Greer and Capecchi, 2002; Zuchner et al., 2006; Chen et al., 2010,  
for review see Camilla et al., 2014). Despite this surge of interest, the neurobiological 
basis of trichotillomania in humans has received scant research attention to date.  
Trichotillomania is a highly familial illness (Keuthen et al., 2014). Genetic and 
environmental factors and their interactions are likely important in its pathogenesis 
(Keuthen et al., 2014; Novak et al., 2009; Chattopadhyay 2012), but the precise nature of 
these factors and their relation with cognitive function and brain structure have not yet 
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been identified. There is a search in psychiatry for objective intermediate biological 
markers, ideally grounded in the neurosciences, which signal ‘risk’ of developing a given 
disorder (termed ‘endophenotypes’) (Gottesman and Gould, 2003). Endophenotypes by 
definition exist not only in patients with a given disorder but also in their clinically 
unaffected first-degree relatives, as compared to individuals with no known family 
history of the condition. While considerable progress has been made in identifying 
candidate endophenotypes for OCD (Fineberg et al., 2010), no studies have examined 
biological markers in unaffected relatives of people with trichotillomania.  
 The brain basis of trichotillomania is unclear; likely there are several key facets of 
the illness. One model emphasizes three key features: Affect dysregulation, behavioral 
‘addiction’ and cognitive dyscontrol (Stein et al., 2006). Emotion dysregulation can play 
a role in the maintenance of trichotillomania, in that hair pulling may act to modulate 
high arousal and low arousal states (Penzel, 2003; Stein et al., 2006; Diefenbach et al., 
2008). Hair pulling can also be considered as a candidate behavioral addiction in view of 
certain parallels with substance addiction (Grant et al., 2007). For example, craving to 
pull hair can escalate over time and this can be transiently relieved by undertaking the 
act; treatments of utility in substance dependence show promise for trichotillomania, e.g. 
opiate antagonists and glutamate modulators (Grant et al., 2009; Grant et al., 2014). 
Cognitive dyscontrol is suggested by neuropsychological assessments conducted in 
patients with trichotillomania. Trichotillomania is associated with impaired inhibitory 
control (Chamberlain et al., 2006; Odlaug et al., 2012), as measured by the Stop-Signal 
Task (SST), a widely used translational computerized paradigm dependent on the 
integrity of the right inferior gyrus and other circuitry (Aron et al., 2014). 
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 Neuroimaging represents a central means of exploring the contribution of neural 
regions relevant to emotional processing, behavioral addiction, and cognitive control, to 
the manifestation of trichotillomania. Earlier studies found evidence for structural 
abnormalities in relevant neural regions, such as reduced grey matter in the putamen and 
left inferior frontal gyrus and increased grey matter in the right cuneus (Grachev, 2007; 
O’Sullivan et al., 2007); and reduced cerebellar volumes (Keuthen et al., 2007). The 
majority of studies to date utilized a region-of-interest (ROI) approach for examining 
cortical abnormalities: this approach relies on pre-existing knowledge of neurobiology 
(which is limited for trichotillomania) and can lead to abnormalities in other regions 
being overlooked (for discussion and review see Chamberlain et al., 2009). Using a 
whole brain voxel-based morphology (VBM) (rather than ROI) approach, excess grey 
matter density has been found in patients with trichotillomania compared to controls, in 
the striatum, amygdalo-hippocampal formation, frontal and cingulate cortices, and 
supplementary motor cortex (Chamberlain et al., 2008; Chamberlain et al., 2009). In a 
recent functional neuroimaging study, patients with trichotillomania exhibited dampening 
of nucleus accumbens responses to reward anticipation (but relative hypersensitivity to 
gain and loss outcomes) as compared to controls (White et al., 2013). Another fMRI 
study did not identify abnormal neural activation during implicit sequence learning in 
patients versus controls (Rauch et al., 2007).  
In terms of brain structure analysis techniques, the VBM approach is not without its 
critics: it potentially confounds several parameters, including changes in grey matter 
thickness, intensity, cortical surface area, and cortical folding (Hutton et al., 2009; Voets 
et al., 2008; for discussion see Kuhn et al., 2013). Therefore, the alternative approach of 
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surface-based morphology has been developed, which is capable of exquisite and 
sensitive characterization of cortical thickness (Dale et al., 1999; Kuperberg et al., 2003; 
Reuter et al., 2012).  
To address these limitations, we undertook a study of response inhibition and 
brain structure in individuals affected by trichotillomania and their clinically 
asymptomatic first-degree relatives. We hypothesized that patients and relatives would 
show impaired inhibition, coupled with abnormal cortical morphometry in neural regions 
involved in inhibitory control (especially the right inferior frontal gyrus), along with 
reduced striatal and cerebellar volumes.  
 
Materials and Methods 
Subjects  
Subjects meeting full DSM-5 criteria for trichotillomania were recruited via 
media advertisements and psychiatric clinic, on the basis of having at least one first-
degree relative being willing to also participate in the research.  
Inclusion criteria for trichotillomania subjects included: 1) Men and women aged 
18 to 65 years with a current primary Diagnostic and Statistical Manual of Mental 
Disorders, Fifth Edition (DSM-5) diagnosis of trichotillomania; 2) no contraindication to 
MRI; and 3) having one or more first-degree relative willing to participate in the research, 
also aged 18-65 years, without trichotillomania or other current psychiatric disorder. 
Exclusion criteria included: 1) unstable medical illness; 2) current pregnancy or 
inadequate contraception; 3) thoughts of suicide; 4) history of bipolar disorder, dementia, 
or psychotic disorder; 5) past 12 months substance use disorder; 6) initiation of behavior 
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therapy or psychotropic medications within the last 6 months; and 7) current use of illicit 
drugs based on urine toxicology. 
For each subject, one clinically unaffected first-degree relative was also contacted 
and enrolled, on the basis of not having current trichotillomania or any other DSM-5 
disorder (by preference, similarly aged same-gendered sibling were enrolled where 
possible). Healthy controls were recruited via media advertisements on the basis of no 
history of psychiatric disorders and no known history of trichotillomania or obsessive 
compulsive related disorders (for example, OCD, excoriation disorder, body dysmorphic 
disorder) in first-degree family members.  
The study procedures were carried out in accordance with the ethical standards 
laid out in the latest version of the Declaration of Helsinki. The Institutional Review 
Board of the University of Chicago approved the study and the consent statement. After 
complete description of the study to the subjects, written informed consent was obtained.  
  
Procedures 
All subjects first received a psychiatric, medical, and family history evaluation. 
Clinical instruments included the Mini International Neuropsychiatric Inventory (MINI) 
(Sheehan et al., 1998), the Massachusetts General Hospital Hairpulling Scale (MGH-
HPS) (Keuthen et al., 1995), the Clinical Global Impressions Severity Scale (CGI-S) 
(Guy, 1976), and the Quality of Life Inventory (QoLI) (Frisch and Cornell, 1993).  
To provide an objective index of inhibitory control, participants then undertook 
the computerized Stop-Signal Test (SST) from the Cambridge Neuropsychological Test 
Automated Battery (CANTAB) (Logan et al., 1984; Aron et al., 2003); this was 
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undertaken in a quiet testing environment outside of the scanner. The details of this task 
are detailed elsewhere (Logan et al., 1984; Aron et al., 2003). In brief, subjects viewed a 
series of directional arrows appearing on-screen one per time, and made rapid responses 
depending on the direction of each arrow (left button for left-facing arrow, and vice 
versa). On a subset of trials, an auditory stop-signal (‘beep’) occurred following 
presentation of the directional arrow, signaling to participants that they should attempt to 
suppress their motor response for the given trial. By varying the time between 
presentation of the ‘go’ stimulus and the stop-signal dynamically using a tracking 
algorithm, the task permitted quantification of stop-signal reaction times (SSRT) – this is 
an estimate of the time taken by an individual’s brain to suppress a response that would 
normally be undertaken, with longer SSRTs equating to worse impulse control. The task 
also recorded median response times for ‘go’ trials and the proportion of successful stops.  
After completion of the above, participants undertook high-resolution structural 
imaging using a 3 Tesla (3T) Philips Achieva Quasar Dual 16 Ch system. Three-
dimensional MPRAGE scan was obtained with imaging parameters: slab orientation = 
sagittal, FOV 256x224x176, voxel size 1x1x1 mm3, inversion delay time TI = 900 ms, 
TR/TE = 8.9/3.7 ms, flip angle = 8 degree. 
 
Data Analysis 
Demographic, clinical, and cognitive characteristics between the study groups 
were compared using one-way analysis of variance (ANOVA, post hoc least significance 
tests where indicated) or alternative non-parametric tests as described in the text. For the 
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purposes of these variables, statistical significance was defined as p<0.05 uncorrected, 
two-tailed.  
MRI scans were processed using FreeSurfer software (version 5.3; 
http://surfer.nmr.mgh.harvard.edu), using methodology that has previous been described 
and validated (Kuhn et al., 2013; Dale et al., 1999; Reuter et al., 2012; Makris et al., 
2003). In brief, scans for each subject were converted to FreeSurfer format and non-brain 
tissue was removed using automated algorithms; the resultant images were then 
transformed to standard Talairach space, segmented, and normalized. After cortical 
reconstruction, cortical thickness was compared between the study groups, using 
permutation cluster analysis with stringent correction for multiple comparisons (cluster-
forming threshold of p<0.001, and cluster-wise p value p<0.05, two-tailed).  We 
identified regions in which subjects and their relatives together differed significantly 
from controls in cortical thickness. Mean thickness in each identified cluster for each 
subject was then extracted and subjected to post hoc tests to further explore group 
differences (Monte Carlo permutation testing).  
Secondary exploratory correlational analyses (Spearman’s r) were used to 
evaluate relationships between: (i) response inhibition and cortical thickness (in all 
participants and then in each subgroup); (ii) response inhibition and disease severity in 
the trichotillomania subjects (MGH-HPS and CGI-Severity scores); (iii) cortical 
thickness and disease severity in the trichotillomania subjects; and (iv) cortical thickness 
and age (in all participants and then in each subgroup). For the purposes of correlational 
analyses, significance was defined as p<0.05 uncorrected, two-tailed. 
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In addition, volumes of a priori selected subcortical structures of interest 
(putamen, caudate, accumbens) were extracted, along with cerebellar cortex volumes, 
using automated parcellation techniques as implemented in FreeSurfer; group differences 
in volumes of these structures were evaluated using ANOVA (p<0.05, uncorrected, two-
tailed).  
 
Results  
The mean MGH-HPS symptom score in the patients was 16.7, consistent with 
moderately severe illness. The 12 randomized patients spent a mean (SD) of 41.0 (35.0) 
minutes each day pulling hair. Patients pulled from several sites: 10 (83.3%) pulled from 
their heads, four (33.3%) from their eyelashes, and two (16.7%) from their eyebrows. 
Three of the patients (25%) had started their pulling before the age of puberty. Of the 12 
patients, only four (33.3%) had sought outpatient mental health treatment specifically for 
hair pulling.  Two patients (16.7%) had ongoing psychotherapy (supportive 
psychotherapy for issues unrelated to trichotillomania) and one (8.3%) was taking a 
psychotropic medication (lorazepam for insomnia). 
Although individuals with one or more current psychiatric co-morbidity were 
excluded, eight enrolled patients (66.7%) reported at least one clinically important 
lifetime comorbid disorder: 5 (41.7%) of the 12 subjects reported symptoms consistent 
with major depressive disorder, and three (25%) had an anxiety disorder. 
Demographic and clinical characteristics of the study groups are summarized in 
Table 1. It can be seen that there was a significant difference between the groups in terms 
of age; post hoc tests indicated that this was due to relatives of patients being 
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significantly older than patients (p=0.004) and tending to be older than controls 
(p=0.083); patients and controls, however, did not differ from each other in terms of age 
(p=0.150). Quality of life scores differed significantly between the groups, with post hoc 
tests indicating that this was due to significantly poorer quality of life in patients 
compared to both other groups (both p<0.01) while relatives did not differ from controls 
(p=0.366).  
Stop-Signal Reaction Times (SSRTs) in each group are displayed in Figure 1. 
Groups differed significantly on SSRTs (F=3.493, p=0.042). Post-hoc tests indicated that 
this was due to patients differing significantly from controls (p=0.016) and relatives 
tending to differ from controls (p=0.082), while patients and relatives did not differ from 
each other (p=0.540). There was no significant differences between the groups in terms 
of median ‘go’ reaction times (mean [SD] TTM: 542.2 [152.3], TTM-Rel: 471.9 [186.5], 
Controls: 509.8 [169.3]; F=1.120, p=0.300) or proportion of successful stops (0.58 [0.07], 
0.52 [0.16]. 0.55 [0.12]; F=1.840, p=0.188).  
 
* FIGURE 1 AND TABLE 1 ABOUT HERE PLEASE * 
Permutation analysis identified two left-hemisphere clusters and three right-
hemisphere clusters in which cortical thickness differed significantly between controls 
and the proband-relative pairs (Table 2). As can be seen in Figure 2, trichotillomania 
patients showed significantly greater cortical thickness in these clusters compared to 
controls, as did their relatives. Patients did not differ significantly from their relatives on 
cortical thickness in these clusters, with the exception of the cluster comprising right 
lateral occipital cortex, in which relatives showed significantly greater cortical thickness 
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than patients. Cortical thickness in these clusters did not correlate significantly with 
response inhibition or age (considered for all subjects together and each group 
separately), nor with disease severity in patients (all p>0.08).  
* TABLE 2 AND FIGURE 2 ABOUT HERE PLEASE * 
The average volumes of selected subcortical regions of interest, and the cerebellar 
cortices, in each study group are indicated in Table 3. It can be seen that no effect of 
group approached significance for striatum volumes (all p>0.10). There was a non-
significant trend for an effect of group on right but not left cerebellar cortex volumes, due 
to numerically lower volumes in relatives and, to a lesser degree, patients versus controls. 
 
* TABLE 3 ABOUT HERE PLEASE * 
 
Discussion  
To the knowledge of the authors, this is the first study to evaluate potential 
biological vulnerability markers for trichotillomania.  The key findings were: (i) that 
groups differed on response inhibition, due to impaired performance in patients, and 
intermediate performance in relatives, versus controls; and (ii) that patients with 
trichotillomania and their unaffected first-degree relatives showed an excess of cortical 
thickness, compared to controls, in several discrete regions: the right middle and inferior 
frontal gyri (BA 11 & 47), right lingual gyrus (BA 18), left superior temporal cortex (BA 
21), and left precuneus (BA 7). These results have important implications for 
understanding the neurobiological basis of trichotillomania and its relationship with other 
conditions.  
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As discussed earlier, the neurobiological basis of trichotillomania is not well 
characterized (Chamberlain et al., 2009). The handful of imaging studies so far provide 
partial support for trichotillomania being associated with smaller left putamen volumes 
(O'Sullivan et al., 1997),  reduced cerebellar volumes (Keuthen et al., 2007), and excess 
grey matter densities in left striatum, left amygdalo-hippocampal formation, and multiple 
cortical regions bilaterally (Chamberlain et al., 2008). Thus, the disorder can be 
conceptualized in terms of abnormalities of cortico-subcortical circuitry involved in 
affect regulation, habit generation and top-down control (Stein et al., 2006). Also relevant 
is the likely role of reward circuitry in trichotillomania, as a recent fMRI study found 
abnormal accumbens activation in patients during a reward task, along with decreased 
accumbens connectivity to other neural regions during the resting state (White et al., 
2013).  In this study, we found common abnormalities of cortical thickness in neural 
regions germane to inhibitory control, emotional processing, and awareness, in patients 
with trichotillomania and their symptomatically unaffected first-degree relatives. 
Consistent with our prediction, excess cortical thickness was found in the right 
medial/inferior frontal gyri (BA 11 & 47), key neural nodes involved in top-down control 
(Aron et al., 2014;Bari and Robbins, 2013; Cromheek and Mueller, 2014). The repetitive 
hair pulling habit characteristic of trichotillomania is strongly suggestive of difficulties 
with top-down response suppression, while deficits on the Stop Signal Task (SST), an 
objective measure of inhibitory control, have been found in patients (Chamberlain et al., 
2006; Odlaug et al., 2012). Also consistent with our hypotheses, we found that the study 
groups differed significantly in terms of response inhibition (SST), due to patients being 
significantly impaired, and relatives occupying an intermediate position, versus controls. 
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As anticipated, groups did not differ significantly on the median reaction time for ‘go’ 
trials on the task, nor for proportion of correct responses.  
Contrary to our prediction, patients did not differ significantly from controls in 
terms of dorsal and ventral striatum volumes. This finding is somewhat discordant with 
the previous report of reduced grey matter in the putamen in trichotillomania (O’Sullivan 
et al., 1997) and with existing neurobiological models implicating the striatum in the 
pathophysiology of the disorder (given its role in reward processing, and habit 
generation). Nonetheless, in contrast to our cortex analysis, the subcortical analysis by 
necessity relied on a region of interest (ROI) approach rather than permutation cluster 
analysis, which may have limited power to detect effects of group. It remains possible 
that the striatum plays a role in trichotillomania but that this is not reflected at a structural 
(as opposed to functional) level. With respect to cerebellar volumes, while groups did not 
differ significantly for cerebellar volumes herein, there was a right-lateralized trend 
towards an effect of group (p=0.054 uncorrected); numerically, cerebellar volumes were 
lower in patient relatives, and, to a lesser degree, patients versus controls. Previous work 
found some evidence for reduced cerebellar volumes in trichotillomania, using a more 
fine-grained method of parcellating particular cortical regions than was utilized here 
(Keuthen et al., 2007).  
The finding of morphometric abnormalities in trichotillomania patients and their 
relatives in the precuneus (BA 7), temporal lobe (BA 21), and lingual gyrus (BA 18), was 
not predicted a priori. In a recent functional magnetic resonance imaging (fMRI) meta-
analysis, the precuneus (BA 7) emerged as a region involved in the integration of 
emotion and top-down cognitive control (Cromheeke and Mueller, 2014). The superior 
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temporal lobe (BA 21) and precuneus form part of neural circuitry involved in memory 
processing (Tulving et al., 1999), there also being some evidence that BA 21 plays a role 
in self-awareness/monitoring according to data from Alzheimer’s Disease (Amanzio et 
al., 2011). Some studies have found mnemonic impairments in trichotillomania 
(Chamberlain et al., 2009). It is intriguing to note that emotion regulation plays a role in 
hair pulling (Shusterman et al., 2009; Rufer et al., 2014). Furthermore, awareness training 
and self-monitoring are core principles of Habit Reversal Therapy (HRT), one of the few 
established effective treatments for the condition (Azrin et al., 1980; Bloch et al., 2007; 
Morris et al., 2013).  Further research will be needed to characterize the functional 
implications of abnormal cortical thickness in these regions in people at risk of 
trichotillomania.  
It is potentially informative to compare the cortical thickness findings in 
trichotillomania to those previously reported for OCD, given the suggested relationship 
between these two conditions, in that trichotillomania is currently conceptualized as an 
OC Related Disorder in the DSM-5. Cortical thickness findings in OCD patients are 
conflicting, with some studies finding increased (Narayan et al., 2008; Fan et al., 2013) 
and other reduced (Kuhn et al., 2013; Venkatasubramanian et al., 2012; Fullana et al., 
2014; Nakamae et al., 2012; Shin et al., 2007) cortical thickness compared to controls. To 
the knowledge of the authors, there have been two studies that have quantified cortical 
thickness in unaffected relatives of OCD patients. Shaw and colleagues reported excess 
cortical thickness in unaffected relatives of patients with OCD versus controls in the right 
lateral prefrontal cortex, left medial temporal lobe, and right precuneus (Shaw et al., 
2014). Peng and coworkers found reduced cortical thickness in OCD patients and their 
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relatives compared to controls, in left parietal and right superior temporal regions (Peng 
et al., 2014). These findings differ considerably from the current findings in people with 
trichotillomania and their relatives, suggesting that the disorders are distinct and likely 
mediated by different vulnerability markers. The findings here for trichotillomania also 
differ from findings in attention-deficit hyperactivity disorder (ADHD), in which reduced 
thickness of the right superior frontal gyrus was found (Almeida et al., 2010; Batty et al., 
2010).  
While this study is the first of its kind in trichotillomania, several caveats should 
be noted. The sample size was relatively small, which may have limited statistical power. 
While this is unlikely to have been problematic for the primary analysis (since we used 
permutation cluster analysis, which permits powerful identification of thickness 
abnormalities yet stringent correction for multiple comparisons), the secondary 
correlational analyses in particular may have been prone to type II error (false negatives). 
The study was neither designed nor powered to investigate effects of medication, therapy, 
or comorbidities on cortical and SST findings in trichotillomania; however, given that 
similar results were found in non-medicated first-degree relatives without symptoms, we 
can refute the possibility that the findings in relatives were substantially mediated by 
these potential confounds. Only two patients were receiving psychotherapy (supportive 
psychotherapy for issues unrelated to trichotillomania) and only one was taking 
psychotropic medication (lorazepam for insomnia) and so we feel that it was unlikely that 
the findings were mediated substantively by these factors. In summary, impaired 
response inhibition and excess cortical thickness in the right middle/inferior frontal gyri, 
and other focal regions, were found in people with trichotillomania and their symptom-
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free first-degree relatives. These biological markers represent candidate endophenotypes 
for this disorder, and appear to overlap only to a limited extent with those already 
identified for OCD. It is conceivable that cortical thickening in neural regions could 
reflect a compensatory response to other areas of impairment, although we did not find 
any regions of reduced cortical thickness in patients. It will be important for future work 
to expand on these results using larger sample sizes, ideally incorporating not only 
structural but also functional brain measures, and to consider their relationship with 
genetic polymorphisms.  
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Table 1. Demographic, Clinical, and Cognitive Findings across the three study groups 
  
TTM  
First-
Degree 
Relatives of 
TTM 
Healthy 
Controls 
ANOVA 
F 
statistic 
p-
value 
(N=12) (N=10) (N=14) 
Age, years  25.8 (4.5) 41.8 (15.1) 32.9 (14.0) 4.749 0.015 
Sex, female, n (%) 11 (91.7%) 8 (80%) 14 (100%)     
Education Score) 3.8 (1.0) 4.0 (0.7) 3.9 (0.9) 0.105 0.9 
Quality of Life Score 24.3 (18.1) 54.4 (18.0) 48.0 (14.9) 10.173 <0.001 
MGH-HPS, total score 16.7 (4.6) N/A N/A     
CGI Severity 4.5 (0.67) N/A N/A     
Values are mean (SD) unless otherwise indicated.  
Abbreviations: MGH-HPS: Massachusetts General Hospital Hairpulling Scale; SSRT = Stop-Signal 
Reaction Time; SST = Stop-Signal Test.  
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Table 2. Results of Permutation Cluster Analysis. Clusters showing significant 
differences in cortical thickness between at risk individuals (patients and relatives) versus 
controls 
      
Cluster peak co-ordinates 
(Talairach)     
Cluster Max 
Area 
(mm
2
) X Y Z 
Cluster p 
value 
Cortical Region 
(Brodmann Area) 
Left Hemisphere 
1 4.206 290.63 -9.8 -44.8 47.3 0.0413 
Parietal lobe, 
precuneus (BA 7) 
2 3.659 164.83 -54.9 -22.2 0.4  0.0364 
Temporal lobe, 
superior temporal 
gyrus (BA 21) 
                
Right Hemisphere 
1 5.333 290.63 26.7 -97.7 -3.6 0.0108 
Occipital lobe, 
lingual gyrus (BA 
18) 
2 4.238 182.45 31.3 29.7 -0.1 0.0304 
Inferior frontal 
gyrus (BA 47) 
3 4.052 165.4 26.7 35.6 -8.3 0.0394 
Middle frontal 
gyrus (BA 11) 
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Table 3. Volumes of subcortical structures and cerebellar cortex across study groups 
(cubic mm) 
  
TTM  
First-
Degree 
Relatives of 
TTM 
Healthy 
Controls 
ANOVA 
F 
statistic 
p-
value 
(N=12) (N=10) (N=14) 
Left caudate  
3810.3 
(306.4) 
3603.4 
(334.2) 
3695.1 
(467.9) 
0.801 0.457 
Left putamen 
6767.4 
(800.8) 
6443.1 
(511.5) 
6153.0 
(768.6) 
2.235 0.123 
Left nucleus accumbens 
751.5 
(115.3) 
763.8 
(118.1) 
820.4 
(135.9) 
1.134 0.334 
Left cerebellar cortex 
48844.3 
(3205.3) 
47234.4 
(3211.2) 
49279.6 
(5697.0) 
0.678 0.515 
Right caudate 
3981.9 
(275.3) 
3734.3 
(370.2) 
3909.1 
(501.0) 
1.076 0.352 
Right putamen 
6136.2 
(451.9) 
5981.9 
(757.9) 
6361.5 
(638.6) 
1.137 0.333 
Right nucleus accumbens 731.9 (88.8) 663.8 (91.4) 
724.8 
(139.5) 
1.527 0.232 
Right cerebellar cortex 
48283.2 
(3342.6) 
46842.9 
(3768.9) 
51199.8 
(5356.9) 
3.186 0.054 
Values are mean (SD) unless otherwise indicated.  
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Figure 1. Inhibitory control performance on the Stop-Signal Test (Stop-Signal Reaction 
Times). Groups differed overall, due to significant impairment in patients versus controls, 
and a trend towards impairment in relatives versus controls. *=p<0.05, LSD test; 
t=0.05<p<0.10; n.s.=p>0.10.   
24 
 
Figure 2. Renderings showing significant clusters of abnormal cortical thickness in 
trichotillomania patients and their relatives compared to controls (red, significant at 
cluster-forming threshold p<0.001, cluster-threshold p<0.05). Graphs indicate extracted 
mean (SEM) thickness in each cluster for each group and post hoc comparisons. ** 
p<0.01, *** p<0.001, by Monte Carlo permutation tests. L = left-hemisphere, R = right-
hemisphere.  
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